Symptom pattern of Meniere's disease often changes over time, study finds

by Lori SolomonMeniere's disease (MD) shows a complex disease course, with initial symptoms decreasing and others persisting and worsening over time, according to a studypublishedonlin

Updated on: December 22,2024

Symptom pattern of Meniere's disease often changes over time, study finds

by Lori SolomonMeniere's disease (MD) shows a complex disease course, with initial symptoms decreasing and others persisting and worsening over time, according to a studypublishedonlin

Updated on:December 22,2024

COVID-19 on the brain: Neurological symptoms persist in majority of long-haulers

byUniversity of California - San DiegoCredit: Pixabay/CC0 Public DomainResearchers at University of California San Diego School of Medicine are conducting a longitudinal study to track neurologi

Updated on: January 21,2024

COVID-19 on the brain: Neurological symptoms persist in majority of long-haulers

byUniversity of California - San DiegoCredit: Pixabay/CC0 Public DomainResearchers at University of California San Diego School of Medicine are conducting a longitudinal study to track neurologi

Updated on:January 21,2024

Alzheimer's researchers use physics techniques to investigate iron storage in the brain

byLeiden UniversityCredit: Matthias Zomer/PexelsExactly how Alzheimer's disease develops is not well understood, but an imbalance of iron in the brain might just play a role. Martina Huber o

Updated on: January 06,2024

Alzheimer's researchers use physics techniques to investigate iron storage in the brain

byLeiden UniversityCredit: Matthias Zomer/PexelsExactly how Alzheimer's disease develops is not well understood, but an imbalance of iron in the brain might just play a role. Martina Huber o

Updated on:January 06,2024

Intranasal delivery of MSCs provides hope for treating Alzheimer's disease

by AlphaMed PressIntranasal injection (IN) of preconditioned MSC-derived EVs (MSC-EVs) affects microglia activation in the brain of 3xTg-AD mice. The image shows the distribution of Iba-1+-microglia (

Updated on: April 29,2024

Intranasal delivery of MSCs provides hope for treating Alzheimer's disease

by AlphaMed PressIntranasal injection (IN) of preconditioned MSC-derived EVs (MSC-EVs) affects microglia activation in the brain of 3xTg-AD mice. The image shows the distribution of Iba-1+-microglia (

Updated on:April 29,2024

Study sheds light on sporadic early-onset Alzheimer's disease, potential target for novel treatment

byScience China PressThis study investigated the clinical features and biomarkers of sEOAD. Findings indicated that these patients showed distinctive clinical presentation, imaging finding and b

Updated on: January 10,2024

Study sheds light on sporadic early-onset Alzheimer's disease, potential target for novel treatment

byScience China PressThis study investigated the clinical features and biomarkers of sEOAD. Findings indicated that these patients showed distinctive clinical presentation, imaging finding and b

Updated on:January 10,2024

Single-cell RNA sequencing reveals heterogeneity in fibrotic scars after spinal cord injury

byChinese Academy of SciencesSchematic diagram of fibrotic scar heterogeneity after spinal cord injury. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-50564-xMyofibrobla

Updated on: September 03,2024

Single-cell RNA sequencing reveals heterogeneity in fibrotic scars after spinal cord injury

byChinese Academy of SciencesSchematic diagram of fibrotic scar heterogeneity after spinal cord injury. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-50564-xMyofibrobla

Updated on:September 03,2024

Scientists use an innovative approach to provide relevant insights into a rare neurologic disorder

by Germans Trias i Pujol Research InstituteLong-read nanopore sequencing of the genomic region including theDAB1ATTTT/ATTTC repeat tract enriched by CRISPR/Cas9.aThe integrativ

Updated on: March 20,2024

Scientists use an innovative approach to provide relevant insights into a rare neurologic disorder

by Germans Trias i Pujol Research InstituteLong-read nanopore sequencing of the genomic region including theDAB1ATTTT/ATTTC repeat tract enriched by CRISPR/Cas9.aThe integrativ

Updated on:March 20,2024

Finding flicker's therapeutic pathway, opening the door to non-invasive treatments for neurodegenerative diseases

by Jerry Grillo,Georgia Institute of TechnologyProposed mechanisms by which 40 Hz flicker changes microglia and cytokine signaling. Credit:Science Advances(2023). DOI: 10.1126/sciadv

Updated on: May 28,2024

Finding flicker's therapeutic pathway, opening the door to non-invasive treatments for neurodegenerative diseases

by Jerry Grillo,Georgia Institute of TechnologyProposed mechanisms by which 40 Hz flicker changes microglia and cytokine signaling. Credit:Science Advances(2023). DOI: 10.1126/sciadv

Updated on:May 28,2024

Newly found genetic variant defends against Alzheimer's disease

byColumbia University Irving Medical CenterCredit: Pixabay/CC0 Public DomainColumbia researchers have discovered a genetic variant that reduces the odds of developing Alzheimer's disease by

Updated on: April 27,2024

Newly found genetic variant defends against Alzheimer's disease

byColumbia University Irving Medical CenterCredit: Pixabay/CC0 Public DomainColumbia researchers have discovered a genetic variant that reduces the odds of developing Alzheimer's disease by

Updated on:April 27,2024

New Alzheimer's drug shines light on need for assessments to head off 'a tsunami of cognitive afflictions'

by University of Southern CaliforniaCredit: Pixabay/CC0 Public DomainTwo stories dominated Alzheimer's news this year: The FDA's approval of Leqembi, the first drug to slow progression of

Updated on: February 24,2024

New Alzheimer's drug shines light on need for assessments to head off 'a tsunami of cognitive afflictions'

by University of Southern CaliforniaCredit: Pixabay/CC0 Public DomainTwo stories dominated Alzheimer's news this year: The FDA's approval of Leqembi, the first drug to slow progression of

Updated on:February 24,2024

Team develops gene therapy to 'pre-treat' neuroblastoma tumors

by Kim Horner,University of Texas at DallasSchematic detailing the experimental procedure and the proposed mechanisms of action of iNOS gene therapy. Credit:Theranostics(2023). DOI:

Updated on: January 02,2024

Team develops gene therapy to 'pre-treat' neuroblastoma tumors

by Kim Horner,University of Texas at DallasSchematic detailing the experimental procedure and the proposed mechanisms of action of iNOS gene therapy. Credit:Theranostics(2023). DOI:

Updated on:January 02,2024

Study finds motorist disorientation syndrome is not only caused by vestibular dysfunction

byIOS PressHistogram to show the relationship between the duration of symptoms and whether treatment helped. Credit:Journal of Vestibular Research(2023). DOI: 10.3233/VES-220088A lar

Updated on: January 10,2024

Study finds motorist disorientation syndrome is not only caused by vestibular dysfunction

byIOS PressHistogram to show the relationship between the duration of symptoms and whether treatment helped. Credit:Journal of Vestibular Research(2023). DOI: 10.3233/VES-220088A lar

Updated on:January 10,2024